TRAXFirst Tracks Biotherapeutics, Inc.Earnings in 9 days

Nasdaq GSBiotechnologyMarket cap $1.55BReports Nov 5, 2026

First Tracks Biotherapeutics, Inc.

Rare disease
Sector
Healthcare
Industry
Biotechnology
Market cap
$1.55B
Employees
104
Exchange
Nasdaq GS
Country
United States
43.48−1.29% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Automated read

There is not enough moving-average history yet for a mid-term technical read.

Readings, end-of-day Oct 26, 2026
RSI (14)Neutral47.36
MACD / signalAbove signal line-1.39 / -1.78, favorable reading
SMA 50Price above39.25, favorable reading
SMA 200——
EMA 20Price above34.78, favorable reading
ADX (14)Rangebound16.83
Show all 12 readings
+DI / −DI+DI leading28.11 / 17.56
ATR (14)7.0% of price — elevated daily swings3.07, flagged reading
Stochastic %KMid-range41.87
Bollinger bands (20)Above upper band: stretched29.34 – 39.80
ROC (10)Positive over 10 sessions3.55, favorable reading
Trend / momentum impulseTrend and momentum agreeBoth rising, favorable impulse reading
Full analysis

What unlocking TRAX reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when TRAX's analysis runs, rather than checked against its stored data now.

Every section above, argued on TRAX's own numbers, on one page.

See what TRAX costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full TRAX analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get TRAX + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does First Tracks Biotherapeutics, Inc. report earnings?

First Tracks Biotherapeutics, Inc. (TRAX) is scheduled to report earnings on Nov 5, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock TRAX